Literature DB >> 7985032

Survival of Chilean patients with systemic lupus erythematosus.

L Massardo1, M E Martínez, S Jacobelli, L Villarroel, H Rosenberg, S Rivero.   

Abstract

Environmental, genetic, and ethnic factors seem to be involved in the expression of systemic lupus erythematosus (SLE). It has been reported that SLE in the Spanish-heritage population is more common and severe than in the white population in the United States. Data on the population with SLE in South America are scarce, however. The survival of 218 Chilean patients with SLE was studied. General features of the disease were similar to those in most reports. Survival at 10 years was 79%. Prognostic factors (P < .01) were the clinical markers of renal severity, including clinical stratification of renal disease, SLE disease activity index, thrombocytopenia, thromboembolism, and the use of "megadose" corticosteroids. Multivariate analysis suggested that the disease activity index had the strongest association with outcome (P = .0007); thrombocytopenia added a marginal risk (P = .04). Renal histology was analyzed in 127 patients. Risk factors for survival were clinical renal stage, elevated serum creatinine levels, and high activity index. Chronicity index was not a risk factor. Survival curves for World Health Organization types II and III were better than for type IV (P = .06). Multivariate analysis showed that creatinine levels correlated inversely with outcome (P = .0363). Disease expression of Chilean patients with SLE was similar to that in most reports. Survival was somewhat lower than in developed countries, which may be attributable to socioeconomic and racial factors.

Entities:  

Mesh:

Year:  1994        PMID: 7985032     DOI: 10.1016/0049-0172(94)90094-9

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  12 in total

1.  Prophylactic use of antibiotics and immunisations in patients with SLE.

Authors:  W R Gilliland; G C Tsokos
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

2.  Associations of serum urea, creatinine and uric acid with clinical and laboratory features in patients with systemic lupus erythematosus.

Authors:  Zaixing Yang; Yan Liang; Chang Li; Weiqiang Xi; Renqian Zhong
Journal:  Rheumatol Int       Date:  2011-07-29       Impact factor: 2.631

3.  Clinicopathological correlations of paediatric lupus nephritis.

Authors:  Stephen D Marks; Neil J Sebire; Clarissa Pilkington; Kjell Tullus
Journal:  Pediatr Nephrol       Date:  2006-11-15       Impact factor: 3.714

4.  Development and Verify of Survival Analysis Models for Chinese Patients With Systemic Lupus Erythematosus.

Authors:  Linyu Geng; Wenqiang Qu; Jun Liang; Wei Kong; Xue Xu; Wenyou Pan; Lin Liu; Min Wu; Fuwan Ding; Huaixia Hu; Xiang Ding; Hua Wei; Yaohong Zou; Xian Qian; Meimei Wang; Jian Wu; Juan Tao; Jun Tan; Zhanyun Da; Miaojia Zhang; Jing Li; Huayong Zhang; Xuebing Feng; Jiaqi Chen; Lingyun Sun
Journal:  Front Immunol       Date:  2022-06-24       Impact factor: 8.786

Review 5.  Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: past, present, and future.

Authors:  Noam Jacob; William Stohl
Journal:  Autoimmunity       Date:  2010-02       Impact factor: 2.815

Review 6.  Review: Male systemic lupus erythematosus: a review of sex disparities in this disease.

Authors:  L-J Lu; D J Wallace; M L Ishimori; R H Scofield; M H Weisman
Journal:  Lupus       Date:  2009-11-27       Impact factor: 2.911

7.  Contribution of the initial features of systemic lupus erythematosus to the clinical evolution and survival of a cohort of Mediterranean patients.

Authors:  S Buján; J Ordi-Ros; J Paredes; M Mauri; L Matas; J Cortés; M Vilardell
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

8.  Myocardial perfusion scintigraphy and coronary disease risk factors in systemic lupus erythematosus.

Authors:  E M C Sella; E I Sato; W A Leite; J A Oliveira Filho; A Barbieri
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

9.  Risk of infection in hospitalised children with systemic lupus erythematosus: a 10-year follow-up.

Authors:  Yu-Shu Chen; Yao-Hsu Yang; Yu-Tsai Lin; Bor-Luen Chiang
Journal:  Clin Rheumatol       Date:  2004-04-14       Impact factor: 2.980

10.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.